MENU
Advertisement
View PDF Reprints
View Supplement
Pharmacologic Options for Treating Restenosis
By Osamu Iida, MD, and Yoshimitsu Soga, MD
left-arrow Created with Sketch. Previous Article
Comparing SFA Device Trials
By Michael R. Jaff, DO
Next Article right-arrow Created with Sketch.
The Restenosis Conundrum
How are reoccuring lesions in the SFA best treated and managed?
View Issue
Laser Atherectomy Versus Intravascular Lithotripsy for Calcified Femoropopliteal Disease
By Nicolas W. Shammas, MD, MS, FSCAI, FSVM, FACC, FICA
What’s Next for R2P?
With Amit Srivastava, MD, FACC, FABVM, and Shailendra Singh, MD, RPVI, FACC, FSCAI
R2P and the OBL Opportunity: Radial-First Hybrid Access for Lower Extremity Intervention
By Imraan Ansaarie, MD, FCCP, FSCAI, FSVM
The What, Why, and How of Shockwave’s Peripheral Balloon IVL Platform
With Samuel Leonard, MD, and Mathew Wooster, MD, MBA
Navigating the 2026 Lower Extremity CPT Code Restructure
By Jeffrey G. Carr, MD
A Private Practice Physician’s Experience Treating Chronic Venous Insufficiency
By Robert A. Edwards, DO
The Next Generation in Carotid Stenting
With Edvard Skripochnik, MD; Anish J. Thomas, MD, FACC, FSCAI; and Mehdi Bouslama, MD, MSc
Must-Haves and Wishlists for BTK Devices
With Marianne Brodmann, MD; Yann Gouëffic, MD, PhD; and Michael C. Siah, MD
